Search

Search Constraints

You searched for: Author/Creator Mian, Christine

Search Results

2. Comparison of 2 new real‐time polymerase chain reaction–based urinary markers in the follow‐up of patients with non–muscle‐invasive bladder cancer. Issue 5 (24th January 2020)

4. Diagnostic predictive value of the Bladder EpiCheck test in the follow‐up of patients with non–muscle‐invasive bladder cancer. Issue 7 (2nd June 2019)

5. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer. Issue 2 (24th October 2018)

6. Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update. (March 2021)

7. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Issue 5 (2nd December 2013)

8. Recurrence and progression in patients with non‐muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. (19th June 2014)

9. Response to Editorial Comment from Dr Todenhöfer and Dr Schwentner to Recurrence and progression in patients with non‐muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. (19th June 2014)